Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2007, p. 3218-3223, Vol. 45, No. 10
0095-1137/07/$08.00+0 doi:10.1128/JCM.02140-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Pediatrics,1 Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Sapporo,2 Advanced Medicine Research Department, Mitsubishi Chemical Medience Corporation, Tokyo, Japan3
Received 17 October 2006/ Returned for modification 27 December 2006/ Accepted 1 August 2007
A new human virus, provisionally named human bocavirus (HBoV), was discovered by Swedish researchers in 2005. A new immunofluorescence assay using Trichoplusia ni insect cells infected with a recombinant baculovirus expressing the VP1 protein of HBoV was developed, and the levels of immunoglobulin G antibody to the VP1 protein of HBoV in serum samples were measured. The overall seroprevalence rate of antibodies against the VP1 protein of HBoV in a Japanese population aged from 0 months to 41 years was 71.1% (145 of 204). The seropositive rate was lowest in the age group of 6 to 8 months and gradually increased with age. All of the children had been exposed to HBoV by the age of 6 years. A rise in titers of antibody against the VP1 protein of HBoV during the convalescent phase was observed for four patients with lower respiratory tract infections, and HBoV DNA was detected in nasopharyngeal swab and serum samples from all four patients. These results suggest that HBoV is a ubiquitous virus acquired early in life and that HBoV might play a role in the course of lower respiratory tract infections.
Published ahead of print on 15 August 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»